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Abstract 
 
To assess among parents longitudinal predictors of human papillomavirus vaccination uptake for their 
daughters, random samples of parents were identified via municipal services and sent baseline 
questionnaires in June 2009 and follow-up questionnaires in November 2011 after their uptake 
decision. Hierarchical logistic regression analysis was used to assess whether demographic 
characteristics, and affective and social cognitive factors, predicted uptake at follow-up. Response 
rates of the baseline and follow-up questionnaire were 29.8% (1762/5918) and 74.3% (793/1067), 
respectively. Uptake was predicted by a later (2011) versus earlier (2010) decision about uptake since 
HPV vaccination implementation (OR 2.48; 95%CI: 1.11-5.52), anticipated regret about no uptake (OR 
1.43; 95%CI: 1.08-1.89), and intention (OR 2.61; 95%CI: 1.47-4.61). There was an interaction 
between ambivalence and attitude (OR 1.68; 95%CI 1.14-2.47): parents with a positive attitude and a 
high ambivalence towards vaccination were more likely to have their daughter vaccinated than parents 
with a positive attitude and a low ambivalence. An informed choice about uptake (5/7 correct items) 
was made by 44%. In conclusion, uptake was predicted by intention, a later (2011) versus earlier 
(2010) decision, and by anticipated regret about no uptake. Decisions regarding new vaccines are 
difficult to make, we recommend a well-balanced implementation process.  
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Introduction 
In Europe 60,000 women are diagnosed with cervical cancer annually (1). Cervical cancer can only 
develop in the presence of infection with high-risk human papillomavirus (HPV) (2-3). Two vaccines 
are available which protect against HPV 16 and 18, which together cause about 70% of cervical 
cancers (4). Preferably, the HPV vaccine is given prior to the initiation of sexual activity because the 
degree of protection is reduced after HPV infection and the incidence of HPV infection is highest in the 
first months after sexual debut (5-6).  
In November 2008 the Dutch National Immunization Program (NIP), which is free of charge 
and voluntary, was extended with HPV vaccinations for 12-year-old girls. The effectiveness of the NIP 
depends on the availability of high-quality vaccines and acceptance by parents (7). Although childhood 
vaccination is well accepted among parents in the Netherlands, with a 95% vaccination rate (8), 
uptake rates of the HPV vaccine are much lower (58% in 2010) (9). In the Netherlands, 12-year-old 
girls are legally entitled to make their own decision about uptake. In practice, however, parents play a 
considerable role in the decision-making about the uptake of HPV vaccinations (10-11).  
The present study aims to elucidate which psychosocial factors of parents predict intended 
and actual HPV vaccination uptake. Previous studies examining (HPV) vaccination behavior (12-14) 
have generally relied on psychosocial concepts derived from the Theory of Planned Behavior (TPB) 
(15) and the Health Belief Model (HBM) (16). Both models are useful in explaining HPV vaccination 
uptake. The TPB proposes that the most proximal determinant of behavior is intention which, in turn, is 
guided by three constructs: attitudes towards the behavior (i.e., the evaluation of advantages and 
disadvantages of a behavior), social norms (perceived approval or support of others), and perceived 
behavioral control (perceived ease of performing a behavior). In accordance with the TPB, the HBM 
suggests that behavior is the result of the evaluation of advantages and disadvantages of a behavior. 
However, the HBM suggests that an important prerequisite of such an evaluation is the perceived 
severity and personal susceptibility of acquiring an illness.  
Although these models are useful in explaining behavior towards vaccination, including HPV 
vaccination, these models generally neglect more affective components that are likely to influence the 
decision about and actual uptake of HPV vaccination (17). Such affective factors may explain the 
vaccination behaviour, beyond the more cognitive predictors (18). In focus group discussions on 
decisions to vaccinate against HPV among parents of HPV vaccination eligible girls, factors that 
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played a role were the perceived lack of knowledge about HPV vaccination (risk), the felt ambivalence 
about the decision to vaccinate (simultaneous positive and negative evaluations of an attitude object) 
(19-20), (dis)trust in authorities, perceived parental responsibility, and the anticipation of regret of (not) 
acting (21). These findings underpin observations that the first HPV vaccination campaigns were met 
by (parental) concerns about the reliability of the vaccine. Therefore, in the present study, we 
assessed whether HPV vaccination uptake was predicted by anticipated regret (22), (dis)trust in health 
authorities (23), ambivalence, social norm, intention, knowledge and/or perceived severity and risk of 
cervical cancer. In addition to studying predictors of HPV vaccination uptake, changes in parental 
knowledge, attitudes and ambivalence were explored both before and after their decision about 
uptake.  
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Methods 
Respondents  
Questionnaires were sent to parents who had not yet made the decision to have their daughter 
vaccinated against HPV, but had to decide within 3-15 months when their daughters become 12 years 
of age. In the Netherlands, all girls receive an invitation to get vaccinated with the bivalent HPV 
vaccine (free of cost) in the year they turn 12 years of age.  
 
Procedure  
Random samples of parents were identified via four municipal health services spread throughout the 
Netherlands. These municipal services hold the addresses of all girls eligible for HPV vaccination in 
their region. The Dutch vaccination program offers one opportunity to get vaccinated against HPV, i.e. 
at age 12. The baseline questionnaire and an information letter were sent by mail to 5918 parents in 
June 2009 (the information letter was addressed to both parents). Parents could return the completed 
questionnaire in a self-addressed envelope. The questionnaire was pilot tested to check for face 
validity and for problems in interpretation (n=10).  
In the baseline questionnaire we asked parents if they were willing to complete a follow-up 
questionnaire after the uptake decision. After the baseline questionnaires were sent, the Mexican flu 
(H1N1 virus) outbreak in the summer of 2009 led to the implementation of an H1N1 vaccination 
program. Therefore, the HPV vaccination programs were postponed until March 2010 and March 
2011. Those who consented to complete a follow-up questionnaire received this questionnaire in 
November 2011.  
The study was approved by the Medical Ethics Committee, of the Erasmus MC Rotterdam. 
 
Baseline questionnaire  
Factors derived from HBM 
Perceived risk and severity. One single item assessed parents’ perceived risk of their daughter getting 
cervical cancer if she was vaccinated, and one additional item assessed the perceived severity if their 
daughter would get cervical cancer. Both risk and severity items (adapted from Weinstein, 2000) were 
measured on an 11-point Likert scale, with higher scores indicating a higher risk or severity (24).  
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Factors derived from TPB 
Attitudes towards HPV vaccination. Attitude was assessed using 9 items on a 5-point Likert scale 
phrased as: ‘I think having my daughter getting vaccinated against cervical cancer is…’, (e.g. bad - 
good, unimportant - important; unwise – wise, harmful – beneficial, adapted from Marteau et al., 2001 
& van den Bergh, 2005) (25-26). The total score was calculated as the mean of the 9 items 
(Cronbach’s alpha = 0.94).  
Intention. Parents’ intention to have their daughter vaccinated against cervical cancer was assessed 
with the question: ‘I want to have my daughter vaccinated against cervical cancer’ [response options: 
(definitely not, probably not, not sure (yet), probably, definitely)].  
Parental subjective norms. Social norms were examined using 8 items on a 5-point Likert scale 
measuring the perceived beliefs about and desire to comply with family, partner, general practitioner 
and friends about vaccinating one’s daughter against HPV (Cronbach’s alpha = 0.82) (adapted from 
Tiro et al., 2005) (27). Parents’ normative belief was assessed using a question about what 
percentage of other parents the respondents thought would want the vaccination for their 12-year-old 
daughters (11 options ranging from 0-100%) (adapted from Marlow et al., 2007) (28).  
 
Complementary factors 
HPV knowledge. We developed a knowledge scale with items about HPV, HPV vaccination and 
cervical cancer consisting of 4 true/false/don’t know items (e.g. ‘The HPV vaccination will decrease the 
risk of cervical cancer’) and 3 multiple choice questions with 3 or 4 response options: [e.g. ‘What is the 
protection rate of the HPV vaccine?’ (response options: 55%; 70%; 85%; 100%)]. A total score was 
calculated by summing the correct responses (score range 0-7). 
Decisional evaluation. The subscales satisfaction-uncertainty (e.g. ‘I am satisfied with my decision’, 
Cronbach’s alpha = 0.80) and informed choice (e.g. ‘I made a well-informed choice’, Cronbach’s alpha 
= 0.79) from the Decision Evaluation Scales (29) were included to assess how respondents evaluated 
their decision about having their daughter vaccinated or not. Both scales consisted of 5 items and 
responses were on a 5-point Likert scale (1=strongly disagree; 5=strongly agree). 
Parental responsibility. To asses parental responsibility we used the subscale ‘basic needs – health 
care’ of the Perceptions of Parental Role Scales (30), consisting of 7 items (e.g. ‘Arrange for child to 
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see dentist for routine checkup’) on a 5-point Likert scale (1=not at all important; 5=very important).  
Cronbach’s alpha = 0.73. 
Anticipated regret and worry. To measure anticipated regret and worry we adapted 2 items from 
Korfage et. al., (2011) (31), measured on a 7-point Likert scale: ‘If I don’t have my daughter vaccinated 
against cervical cancer, then I would regret this/then I would worry’ (1=definitely not; 7=definitely). The 
total score was calculated as the mean of the 2 items (Cronbach’s alpha = 0.82).  
Ambivalence. Ambivalence was measured using 2 items regarding positive and negative thoughts 
about HPV vaccination (adapted from Kaplan, 1972) (19): ‘Considering only the positive things about 
HPV vaccination, and ignoring the negative things, then what do you think of HPV vaccination?’ 
(response options: not at all positive; slightly positive; quite positive; extremely positive), and vice 
versa for negative thoughts. Total ambivalence was calculated as half the sum of the positive and 
negative judgments, minus the absolute difference between the two (32).  
Trust. We developed two items to assess trust in the NIP and the HPV vaccine on a 6-point Likert 
scale (1=none; 6=a lot).  
Reasons for vaccinating. Parents’ reasons to have or not to have their daughter vaccinated were 
assessed using 11 predefined items for ‘vaccinating’, 17 items for ‘not vaccinating’, and an option to 
write down additional reasons.  
Parental characteristics. We assessed sex, marital status, educational level, job status, ethnicity and 
religion of the parents. Female respondents were asked about their perceived risk of getting cervical 
cancer themselves (11-point Likert scale) (adapted from Marlow et al., 2007) (24) and if they had ever 
had an abnormal pap smear result.  
 
Follow-up questionnaire 
In the follow-up questionnaire we again assessed knowledge, attitude towards HPV vaccination, 
decisional evaluation, social norms (without compliance items, because compliance will logically not 
change over time), ambivalence, risk perception and severity, and trust. In addition, vaccination 
uptake was assessed. 
An informed choice to participate or not (33-34), i.e. a choice based on relevant knowledge, 
consistent with the decision-maker’s values and behaviourally implemented (25), was calculated using 
knowledge (at follow-up), attitude (at baseline), and uptake. Since there is no standard cut-off to 
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measure sufficient decision-relevant knowledge, we presented rates of informed decisions for 3, 4, 5 
and 6 correct items (out of 7). As an example, results with the cut-off level of 5 correct items are fully 
displayed. An informed choice to have one’s daughter vaccinated is characterized by sufficient 
decision-relevant knowledge, a positive attitude towards HPV vaccination (score >3), and having one’s 
daughter vaccinated. An informed choice not to have one’s daughter vaccinated is characterized by 
sufficient decision-relevant knowledge, a negative attitude towards HPV vaccination (score <3), and 
not having one’s daughter vaccinated. An attitude score of 3 was defined as neutral.  
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Data analyses 
The significance of mean and frequency differences between the baseline and follow-up group was 
assessed with the Mann-Whitney U test and Chi-square statistics. Pearson correlations were 
calculated to analyze associations between parent characteristics and social cognitive factors . To 
determine significant predictors of uptake (yes/no) measured at follow-up (T2), multiple hierarchical 
logistic regression analyses were performed with various factors measured at baseline as independent 
variables . In model 1 demographic characteristics were entered, because these were considered 
more distal and non-modifiable predictors. In model 2a parent characteristics were added. Model 2b 
consisted of demographic characteristics and social cognitive factors. In model 3 we entered 
demographic characteristics, parent characteristics, social cognitive factors, and an interaction term of 
attitude x ambivalence. Finally, in model 4 intention was added. Intention was added only in the last 
model because of its high correlation with other predictors. We aimed to show significant predictors 
with and without intention in the model. The procedure recommended by Aiken and West (1991) was 
used to determine whether ambivalence moderated the relationship between attitude and uptake, and 
the unstandardised regression coefficients were examined for attitude at different levels of 
ambivalence (i.e. the mean ambivalence score, 1 SD above the mean, and 1 SD below the mean) 
(35). To compare predictors of uptake and intention, the regression analysis of model 3 was repeated 
with intention as the dependent variable (ordinal logistic regression analyses).  
 To assess the impact of the time gap between baseline and follow-up on changes in attitude 
and ambivalence, two linear regression analyses were performed with change scores between the 
baseline and follow-up measurement. Variables that showed a significant (p<0.05) change over time 
were included. First, we used attitude as the dependent variable. Independent variables were 
knowledge, informed choice (subscale of the Decision Evaluation Scales (29)), ambivalence towards 
HPV vaccination, social norm, and trust in the vaccine. Second, we used ambivalence towards HPV 
vaccination as the dependent variable. Independent variables were knowledge, informed choice, 
social norm, and trust in the vaccine.  
McNemar’s test was used to assess the significance of the difference in correct responses to 
the knowledge items between baseline and follow-up .  
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Results  
Respondents 
The response rate of the baseline questionnaire was 29.8% (1762/5918). A total of 1067 respondents 
were willing to complete the follow-up questionnaire, of which 793 responded (74.3%) (Figure 1). At 
baseline, the mean age of those who completed both questionnaires was 43 years. Most respondents 
were female (baseline: 93.3%; follow-up: 93.7%), had an intermediate (baseline: 47.9%; follow-up: 
46.7%) or high educational level (baseline: 40%; follow-up: 45.0%), and were born in the Netherlands 
(baseline: 91.0%; follow-up: 93.8%). In the follow-up group, 652 (82.2%) daughters had been 
vaccinated against HPV. The subgroup that completed the follow-up assessment differed significantly 
from those who did not, on six characteristics (Table 1).  
 
Predictors of HPV vaccination uptake 
Pearson’s correlations showed that most associations between the predictors were positive (Table 2). 
Table 3 presents the results of the hierarchical logistic regression analyses to predict HPV vaccination 
uptake. The first model in which HPV vaccination uptake was regressed on demographic factors 
showed that uptake at follow-up was significantly predicted by religion, and the year the decision about 
uptake was made (2011 vs. 2010) (pseudo R2 = 0.06). Specifically, those respondents without a 
religious affiliation and those who had to decide in 2011 were more likely to have their daughter 
vaccinated. In model 2a, parent characteristics were added; this model explained an additional 29% 
variance. HPV vaccination was more likely for parents with a higher educational level, having no 
religious affiliation, decision about uptake in 2011, and higher trust in the NIP and the vaccine. In 
model 2b (demographic characteristics and social cognitive factors) significant predictors were: year of 
decision about uptake (2011 vs. 2010), a positive attitude towards HPV vaccination, social norm, and 
anticipated regret and worry about no uptake (pseudo R2 = 0.53). In model 3 (including all predictors 
except intention), vaccination was more likely for parents who had to decide in 2011, ambivalence 
towards HPV vaccination (under the condition that attitude is equal to 0), and higher anticipated regret 
and worry about no uptake. The interaction term of attitude x ambivalence was also significant 
(pseudo R2 = 0.57). In model 4 (including all predictors), significant predictors of uptake were the year 
the decision about uptake was made (2011 vs. 2010), a higher intention, ambivalence towards HPV 
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vaccination (under the condition that attitude is equal to 0), and the interaction term of attitude x 
ambivalence. 
 The significant interaction term attitude x ambivalence showed that the predictive validity of 
attitude improved as scores of ambivalence increased from low (b=0.89, p=0.0238) to moderate 
(b=1.44, p=0.001), and from moderate (b=1.44, p=0.001) to high (b=1.98, p<0.001).   
 
Associations of HPV vaccination intention  
Alternatively, we performed an ordinal logistic regression analysis with intention (instead of uptake) as 
dependent variable (results not shown). This analysis showed that a higher intention was associated 
with a positive attitude towards HPV vaccination (OR 19.53; 95%CI: 10.32-36.93) (under the condition 
that ambivalence is equal to 0), ambivalence towards HPV vaccination (OR 2.39; 95%CI: 1.10-5.18) 
(under the condition that attitude is equal to 0), trust in the vaccine (OR 1.62; 95%CI: 1.16-2.27), 
anticipated regret and worry about no uptake (OR 1.59; 95%CI: 1.32-1.92), and social norm (OR 1.07; 
95%CI: 1.04-1.10). A lower uptake intention was associated with a higher educational level (OR 0.83; 
95%CI: 0.70-0.99) and a higher perceived parental responsibility for their daughter’s health (OR 0.48; 
95%CI: 0.30-0.75). The interaction term of attitude x ambivalence was significant (OR 0.73; 95%CI: 
0.59-0.90). 
 
Impact of time 
Favorable changes in attitudes towards HPV uptake over time were significantly related to an increase 
in trust in the vaccine (OR 1.45; 95%CI: 1.36-1.53) and social norm (OR 1.22; 95%CI: 1.15-1.28) over 
time, and a decrease in ambivalence towards HPV vaccination (OR 0.94; 95%CI: 0.91-0.98). A 
decrease in ambivalence towards HPV vaccination over time was significantly related to an increase in 
feeling informed about HPV vaccination (OR 0.79; 95%CI: 0.69-0.91) and an increase in trust in the 
vaccine (OR 0.88; 95%CI: 0.77-0.99) over time.  
 
Informed decision-making  
Overall, knowledge levels about the degree/duration of protection was low at baseline and at follow-up 
(33-43% correct answers). Percentages of correct responses to 5 knowledge items increased 
significantly at follow-up (Table 4). When 5 (out of 7) correct items were defined as sufficient decision-
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relevant knowledge, then n=338 (43.9%) of the respondents made an informed choice about uptake. 
When 4 correct items were considered sufficient, then n=437 (65.7%) of the respondents made an 
informed choice about uptake (Table 5). 
 
Reasons for vaccinating or not 
Main reasons as reported by parents at baseline to have their daughter vaccinated include feeling 
responsible for her health (n=947; 54.9%), a family history of cancer (n=128; 7.4%), anticipating regret 
in case their daughter gets cervical cancer (n=103; 6.0%), and other (n=547; 31.7%). Main reasons as 
reported by parents at baseline not to have their daughter vaccinated include that consequences of 
vaccinating are unpredictable (497; 28.8%), fear of serious side-effects (n=401; 23.2%), and too little 
information about the vaccine being available (n=125; 7.2%).  
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Discussion  
In this study among parents we assessed longitudinal predictors of HPV vaccination uptake of their 
daughters. Uptake was predicted by intention, a later (2011) versus earlier (2010) decision about 
uptake, and anticipated regret and worry in case of abstaining from HPV vaccination. Ambivalence 
towards HPV vaccination at baseline moderated the attitude (baseline)- uptake (follow-up) 
relationship, with the attitude-uptake relationship being stronger at higher ambivalence levels.  
HPV vaccination was most strongly predicted by intention, which fits the TPB model and was 
also reported in an earlier study on predictors of HPV vaccination uptake (22). In turn, HPV 
vaccination intention was positively associated with educational level, perceived parental responsibility 
for one’s daughter’s health, trust in the vaccine, the belief that according to significant others their 
daughter should be vaccinated, and the motivation to comply with that (social norm), and anticipated 
regret and worry (which also predicted uptake). The relationship found between intention and uptake, 
and between intention and social norm, is consistent with the TPB model and with another study (22) 
which also confirms the association we found between anticipated regret/worry and uptake, and 
anticipated regret/worry and intention. The factors ‘perceived susceptibility’ and ‘severity’ of cancer of 
the HBM were not associated with intention or uptake, which confirms the results of an earlier study 
(22, 36).  
A possible explanation for the positive effect on uptake of having to decide later (2011) versus 
earlier (2010) might be the amount of time that passed between the baseline questionnaire (2009) 
when an intensive societal debate involving politics, physicians, media, parents and girls about HPV 
vaccination was ongoing and the actual decision about uptake of vaccination. In 2011 this debate 
probably had less impact on the uptake decision than in 2010. Also, after millions of girls worldwide 
had been vaccinated and no serious side-effects had been reported, parents who had to decide later 
versus earlier probably felt more reassured about the vaccine’s safety.  
The present study shows that ambivalence moderated the attitude-uptake relationship. 
Parents with a positive attitude and a high level of ambivalence towards HPV vaccination were more 
likely to have their daughter vaccinated than parents with a positive attitude and a low level of 
ambivalence. This finding might be explained in two ways. First, ambivalence is characterized as 
being subjectively uncomfortable and people may be motivated to resolve the conflicting evaluations 
that they hold (37), e.g. by searching for information. Second, earlier studies found that ambivalent 
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people processed pro-attitudinal messages to a greater extent than counter-attitudinal messages, 
probably because pro-attitudinal messages are more likely to reduce ambivalence (38-39). Taking 
these two mechanisms together, it is likely that in our study ambivalent parents with a positive attitude 
towards HPV vaccination processed ‘positive’ messages about HPV vaccination to a greater extent 
than ‘negative’ messages, and were therefore more likely to have their daughter vaccinated. In other 
words, parents who had both positive attitudes and were ambivalent towards HPV vaccination, 
became even more positive because they elaborated only information in favor of HPV vaccination.  
This may imply that this ‘biased’ information processing has a negative impact on informed decision-
making, although parents will have gained more knowledge during their efforts to resolve their 
ambivalence. 
 Assessing decisional factors related to HPV vaccination both before and after the decision-
making process about uptake, provided a unique opportunity to determine changes in those factors 
over time. Since uptake was predicted by intention, and intention was highly correlated with attitude 
(r=0.84) (at baseline), we think it is relevant to show which factors are important for changes in attitude 
over time. Our results show that a more positive attitude towards HPV vaccination over time was 
associated with an increase in trust in the vaccine and in social norm over time, and a decrease in 
ambivalence towards HPV vaccination over time. This latter factor was related to an increase in 
feeling informed about HPV vaccination and an increase in trust in the vaccine over time. In summary, 
over time parents felt better informed, became less ambivalent and had more trust in the vaccine. 
These results are in accordance with our finding that girls who had to decide with their parents 
whether or not to be vaccinated in 2011, were more likely to be vaccinated than those who had to 
decide in 2010.  
An important finding is that knowledge about the duration of protection was low at both 
baseline and follow-up. For instance, about 65% of the parents thought that protection lasts 30 years 
or even lifelong. Since the duration of protection is still unknown, it is important that parents and girls 
know that booster vaccinations might be needed in the future. When we applied a cut-off of 4 or 5 
correct knowledge items (out of 7), then the rates of informed choice about uptake were not high, 66% 
and 44%, respectively. However, this finding should be interpreted with caution because the time 
period between the assessment of knowledge and the last vaccination out of 3 shots was 1 month 
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(decision in 2011) or 14 months (decision in 2010). In educational material it should be clearly stated 
what is known and not yet known about HPV vaccination. 
Study strengths include: the longitudinal design, as recommended by authors of a cross 
sectional study (40); the high (absolute) number of respondents of the baseline (n=1725) and follow-
up questionnaires (n=793); and the high response rate of the follow-up questionnaire (74%).  
 
Limitations  
A limitation was the low response rate of the baseline questionnaire (30%), which might be due to the 
length of the questionnaire. Our sample may therefore not be representative of the general population,  
as few parents had a low educational level. Also, demographic characteristics of the follow-up group 
were slightly different from those of the baseline group, with more parents being better educated and 
well-off at follow-up. These parents might possibly be more likely than those in the wider population to 
seek to reduce high ambivalence by searching information, allowing them to respond positively to the 
vaccine invitation - rather than do nothing. 
 
Conclusion 
In conclusion, this study shows that intention, a later versus earlier decision about uptake, and 
anticipated regret/worry about abstaining from vaccination were predictors of uptake. Anticipated 
regret was a common predictor of intention and uptake and thus an important factor in the decision-
making process about HPV vaccination. In turn, predictors of intention, like social norm and trust in the 
vaccine, are also important when deciding about HPV vaccination. Over time, parents felt better 
informed, became less ambivalent and had more trust in the vaccine.  
 
Practice implications 
This study shows the usefulness of including affective factors in studies examining HPV vaccination 
behaviour, since anticipated regret, trust in the vaccine, and ambivalence were found to play a role in 
the decision-making about uptake. However, it is also important that parents are enabled to base their 
decision about HPV vaccination of their daughter on decision-relevant knowledge. Since these results 
suggest that people need sufficient time to decide about the uptake of a new vaccine, we recommend 
a well-balanced, stepwise process of implementation, i.e. let parents first become aware of the link 
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between HPV and cervical cancer, then provide them with balanced information about all the knowns 
and also the unknowns of HPV vaccination, and then finally offer them the opportunity to have their 
daughter vaccinated. Since two third of parents wrongly thought that protection lasts 30 years or even 
lifelong, educational material should clearly state that booster vaccinations might be needed in the 
future.   
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Table 1: Characteristics of the respondents (parents).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 Total baseline group 
(n=1725) 
Subgroup that 
completed follow-up 
assessment (n=793) 
 
Characteristics Mean (SD) Mean (SD) p-value 
Age at baseline (years) 
range 
42.8 
29-59 
4.17 43.0 
32-58 
4.05 0.015 
Children      
   Age (years) 13.3 3.42 13.3 3.21  
   Age range  0-34  0-34   
   Number of girls 1.7 0.78 1.7 0.74  
   Number of boys 0.9 0.77 0.9 0.76  
 n % n %  
Marital status      0.372 
   Married/cohabiting  1477 87.2 693 89.4  
   Partner, but living alone 34 2.0 16 2.1  
   No partner  165 9.7 66 8.5  
Sex      0.233 
   Female  1596 93.3 743 93.7  
Educational level      <0.001 
  Low  200 12.1 64 8.3  
  Intermediate  789 47.9 358 46.7  
  High  658 40.0 345 45.0  
Job status     0.270 
   Paid job 1268 78.6 617 81.6  
   Housewife or houseman or unpaid job 
or student 
295 18.3 119 15.7  
   No job 51 3.2 20 2.6  
Net income per month (euros)      <0.001 
   < 1,500 161 10.5 45 6.1  
   1,500 – 3,000 584 38.2 267 36.4  
   3,000 – 4,500 488 32.0 264 36.0  
   > 4,500 294 19.3 157 21.4  
Country of birth      <0.001 
  The Netherlands 1550 91.0 740 93.8  
  Turkey; Morocco 37 2.2 6 0.8  
  Suriname; Aruba; Netherlands Antilles 16 0.9 4 0.5  
  Other  100 5.9 39 4.9  
Country of birth of both parents     0.002 
  The Netherlands 1459 88.5 703 89.4  
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  Turkey; Morocco 44 2.7 9 1.1  
  Suriname; Aruba; Netherlands Antilles 19 1.2 5 0.6  
  Other 126 7.6 69 8.8  
Religion     0.590 
   None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           960 57.0 450 57.9 
   Christian  611 36.3 290 37.3  
   Muslim 57 3.4 13 1.7  
   Other  54 3.2 24 3.1  
Decision about HPV vaccination 
uptake 
     
   In 2010 - - 555 71.5  
   In 2011 - - 221 28.5  
If female: abnormal pap smear result     0.103 
   Yes  185 11.7 98 13.2  
   No  1351 85.6 634 85.3  
   Never had a pap smear taken 42 2.7 11 1.5  
Daughter vaccinated against DPTP
1
 
and MMR
2 
    0.038 
   Yes  1654 95.9 778 98.1  
Daughter vaccinated against HPV      
   Yes  - - 652 83.1  
The subgroup that completed the follow-up assessment differed significantly from the baseline group 
on six characteristics.   
1
 DPTP refers to diphtheria, pertussis, tetanus and poliomyelitis.  
2 
MMR refers to measles, mumps and rubella.  
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Table 2. Means, standard deviations (SD) and Pearson’s correlation between the predictors at baseline (n=793) 1 
 2 
  Mean (SD) 1 2 3 4 5 6 7 8 9 10 11 12 
1. Parental responsibility  4.50 (0.46)             
2. Trust in NIP 4.86 (0.67) 0.04            
3. Trust in vaccine 4.31 (0.92) 0.06 0.54
*
           
4. Perceived susceptibility 
of mother to cervical 
cancer 
4.97 (1.74) 0.05 0.01 0.02          
5. Intention  3.89 (1.07) 0.03 0.48
*
 0.73
**
 0.05         
6. Ambivalence 1.71 (1.07) -0.07 -0.20
**
 -0.26
**
 0.01 -0.29
**
        
7. Attitude towards HPV 
vaccination 
3.73 (1.44) 0.09
**
 0.51
**
 0.77
**
 0.05 0.84
**
 -0.33
**
       
8. Social norm 6.10 (10.31) 0.15
**
 0.33
**
 0.51
**
 0.07 0.61
**
 -0.18
**
 0.64
**
      
9. Normative belief 7.12 (1.57) 0.05 0.19
**
 0.33
**
 0.01 0.33
**
 -0.09
*
 0.34
**
 0.37
**
     
10. Knowledge 4.32 (1.49) -0.09
**
 0.10
**
 0.03 0.03 0.03 -0.07 0.02 0.03 -0.03    
11. Perceived   
susceptibility of daughter 
if vaccinated to cervical 
cancer 
3.73 (1.44) 0.06 -0.23
**
 -0.30
**
 0.41
**
 -0.26
**
 0.03 -0.31
**
 -0.23
**
 -0.23
**
 0.01   
12. Perceived severity of 
cervical cancer 
10.60 (0.93) 0.25
**
 0.04 0.05 0.03 0.05 0.04 0.06 0.07 0.09
*
 -0.12
**
 0.01  
13. Anticipated regret and 
worry about no uptake 
4.92 (1.56) 0.23
**
 0.38
**
 0.62
**
 0.11
**
 0.69
**
 -0.19
**
 0.71
**
 0.53
**
 0.36
**
 -0.06 -0.23
**
 0.20
**
 
Small effect size: r > 0.10; medium effect size: 0.30 < r < 0.50; large effect size: r > 0.50. * p < 0.05 ** p< 0.01.  NIP; Dutch National 
Immunization Program  
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Table 3. Hierarchical logistic regression analyses with uptake (yes/no) as dependent variable: all 5 
variables are reported by parents at baseline.  6 
 Univariate  Model 1 (n=708) Model 2a (n=644) Model 2b (n=617) 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Demographic 
characteristics 
    
  Age of parents 
(years) 
1.02 (0.98-1.07) 1.01 (0.96-1.06) 1.03 (0.96-1.09) 1.02 (0.95-1.10) 
  Educational level 1.15 (1.00-1.34) 1.17 (0.99-1.37) 1.25 (1.00-1.54)* 1.20 (0.93-1.55) 
  No religious  
affiliation  
1.73 (1.19-2.53)** 1.63 (1.09-2.42)* 1.73 (1.07-2.81)* 1.12 (0.63-2.00) 
   Decision about 
uptake: 2011 
(vs. 2010)  
2.08 (1.28-3.36)** 2.68 (1.57-
4.53)*** 
2.69 (1.42-5.10)** 2.45 (1.20-5.01)* 
Parent 
characteristics  
    
   No abnormal 
smear 
experience  
1.02 (0.58-1.78)  0.94 (0.45-1.95)  
   Parental 
responsibility  
1.23 (0.83-1.84)  1.53 (0.91-2.59)  
   Trust in NIP 3.54 (2.61-4.81)***  1.82 (1.21-2.74)**  
   Trust in vaccine 3.64 (2.85-4.64)***  3.41 (2.49-
4.68)*** 
 
   Perceived 
susceptibility of 
mother to 
cervical cancer 
1.04 (0.93-1.16)  1.03 (0.88-1.21)  
Social cognitive 
factors  
    
   Intention  4.59 (3.56-5.92)***    
   Ambivalence 
towards HPV 
vaccination 
0.82 (0.69-0.92)*   1.07 (0.79-1.45) 
   Positive attitude 
towards HPV 
vaccination 
5.73 (4.26-7.71)***   3.43 (2.01-
5.84)*** 
   Social norm  1.21 (1.16-1.26)***   1.07 (1.01-1.13)* 
   Normative belief 1.44 (1.28-1.63)***   0.99 (0.81-1.21) 
   Knowledge 1.08 (0.95-1.22)   0.95 (0.87-1.04) 
   Perceived 
susceptibility of 
daughter if 
vaccinated to 
cervical cancer 
0.65 (0.57-0.74)***   0.86 (0.70-1.05) 
   Perceived 
severity of 
cervical cancer 
1.22 (1.03-1.46)*   1.08 (0.81-1.42) 
   Anticipated 
regret  and 
worry about no 
uptake 
2.23 (1.93-2.58)***   1.43 (1.11-1.84)** 
   Ambivalence x 
attitude 
interaction 
    
R
2 
 0.06 0.35 0.53 
*p < 0.05 **p < 0.01 and ***p < 0.001 
OR, odds ratio. CI, confidence interval.  
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 8 
 9 
 10 
 11 
 12 
13 
 Model 3 (n=572) Model 4 (n=569)
 OR (95% CI) OR (95% CI) 
Demographic 
characteristics 
  
  Age of parents 
(years) 
1.02 (0.94-1.11) 1.01 (0.93-1.09) 
  Educational level 1.27 (0.96-1.70) 1.33 (0.99-1.78) 
  No religious 
affiliation  
1.19 (0.63-2.25) 1.16 (0.60-2.23) 
   Decision about 
uptake: 2011 (vs. 
2010)  
2.48 (1.11-5.52)* 2.60 (1.16-5.80)* 
Parent 
characteristics  
  
   No Abnormal 
smear experience  
0.70 (0.26-1.88) 0.68 (0.24-1.95) 
   Parental 
responsibility  
1.55 (0.76-3.18) 1.86 (0.90-3.83) 
   Trust in NIP 1.40 (0.86-2.30) 1.33 (0.79-2.24) 
   Trust in vaccine 1.23 (0.69-1.83) 0.99 (0.59-1.67) 
   Perceived 
susceptibility of 
mother to cervical 
cancer 
0.97 (0.77-1.22) 0.96 (0.76-1.22) 
Social cognitive 
factors  
  
   Intention   2.61 (1.47-
4.61)** 
   Ambivalence 
towards HPV 
vaccination 
0.27 (0.08-0.87)* 0.22 (0.07-0.71)* 
   Positive attitude 
towards HPV 
vaccination 
1.70 (0.69-4.21) 0.89 (0.34-2.36) 
   Social norm  1.05 (0.99-1.11) 1.03 (0.97-1.09) 
   Normative belief 1.03 (0.83-1.29) 1.03 (0.81-1.29) 
   Knowledge 0.93 (0.76-1.13) 0.95 (0.78-1.17) 
   Perceived 
susceptibility of 
daughter if 
vaccinated to 
cervical cancer 
0.89 (0.69-1.14) 0.88 (0.68-1.14) 
   Perceived 
severity of cervical 
cancer 
1.06 (0.78-1.44) 1.08 (0.79-1.48) 
   Anticipated regret 
and worry about no 
uptake 
1.43 (1.08-1.89)* 1.24 (0.92-1.67) 
   Ambivalence x 
attitude interaction 
1.68 (1.14-2.47)** 1.79 (1.22-
2.62)** 
R
2 
0.57 0.59 
*p < 0.05 **p < 0.01 and ***p < 0.001 
OR, odds ratio. CI, confidence interval.  NIP;  Dutch National 
Immunization Program  
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Table 4: Knowledge items as completed by those who responded to the baseline and follow-up 14 
questionnaire (n=793) 15 
 Correct responses 
 Baseline  
measurement 
 Follow-up 
measurement 
Significance level 
for difference 
between baseline 
and follow-up 
Item (true/false) n %  n % p-value 
HPV causes cervical cancer (true) 496 62.5  479 60.4 0.336 
A condom protects 100% against HPV 
(false) 
464 58.5  518 65.3 0.001 
The HPV vaccination will decrease the 
risk of cervical cancer (true) 
673 84.9  726 91.6 <0.001 
Vaccination in combination with having 
a smear taken is more protective 
than only vaccination (true) 
521 65.7  598 75.4 <0.001 
Item (multiple choice)       
How is HPV transmitted? (through 
blood; oxygen; sexual contact) 
699 88.1  730 92.1 0.006 
What is the protection rate of the HPV 
vaccine (55%; 70%; 85%; 100%) 
286 36.1  337 42.5 0.005 
What is the protection duration of a 
complete vaccination against 
cervical cancer? (at least 6 [8 at 
follow-up] years; at least 30 years; 
lifetime) 
289 36.4  262 33.0 0.094 
Correct answers are shaded 16 
17 
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Table 5: Informed decision at follow-up (n=770)  20 
 21 
 Daughter 
vaccinated  
(n=640) 
 Daughter not 
vaccinated 
(n=130) 
 n %  n % 
Positive attitude       
≥5 correct items 280 36.4  14 1.8 
<5 correct items 246 31.9  16 2.1 
Negative attitude       
≥5 correct items 51 6.6  58 7.5 
<5 correct items 32 4.2  34 4.4 
 Knowledge was measured with 7 items at follow-up. Informed decision rate for cut-off at 3 correct 22 
items: 76.1% ([504+82]/770); 4 correct items: 65.7% ([437+69]/770); 5 correct items: 43.9% 23 
([280+58]/770); 6 correct items: 18.7% ([117+27]/770). Due to missing items, analyses were based on 24 
n=770 respondents instead of n=793.  Informed choice (as defined) is shaded. 25 
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